SCHEMBL29415372

SCHEMBL29415372

Cc1cc(Cc2cc(C)cc(C(C)(C)C)c2O)c(O)c(C(C)(C)C)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPA5 P11021 2/20 1.00
CYP2C9 P11712 5/20 0.96
CYP2C19 P33261 5/20 0.96
HIF1A Q16665 5/20 0.96
SMN1; SMN2 Q16637 5/20 0.96
CYP2D6 P10635 3/20 0.83
HSD17B10 Q99714 1/20 0.83
ALDH1A1 P00352 5/20 0.68
CA2 P00918 3/20 0.68
POLB P06746 1/20 0.68
TYR P14679 1/20 0.68
AMY1A P0DUB6 1/20 0.50
CA1 P00915 2/20 0.46
TP53 P04637 2/20 0.46
CYP1A2 P05177 5/20 0.45
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
TSHR P16473 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41
LMNA P02545 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34162 1.00 HSPA5 (1.00) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL29351672 1.00 HSPA5 (1.00) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL11247674 0.98 CYP2C9 (1.00) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL39149 0.98 CYP2C9 (1.00) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL29357108 0.98 CYP2C9 (1.00) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL29410654 0.98 HSPA5 (0.96) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
Methoxymethane SCHEMBL9414514 0.94 HSPA5 (0.89) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
Ethylene Glycol SCHEMBL11769531 0.94 HSPA5 (0.89) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL13263151 0.93 HSPA5 (0.86) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL8630259 0.93 HSPA5 (0.86) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509576-B2 Stabilized polymer compositions HITACHI ENERGY LTD (CH) 2025-12-30 US claimed
WO-2024141746-A1 FUEL ADDITIVE COMPOSITION COMPRISING AT LEAST ONE SECONDARY ARYLAMINE AND AT LEAST ONE NITROXIDE TOTALENERGIES ONETECH (FR) 2024-07-04 WO claimed
CN-110663090-B Stabilized polymer composition 日立能源瑞士股份公司 2023-10-10 CN claimed
WO-2026097979-A1 FLAME-RETARDANT MATERIAL, AND PREPARATION METHOD THEREFOR AND PRODUCT THEREOF 江苏博云塑业股份有限公司 2026-05-15 WO disclosed
CN-117203185-B Diisocyanate stabilizer, use thereof and diisocyanate composition 巴斯夫欧洲公司 2026-05-12 CN disclosed
US-20260078239-A1 USE OF AN ANTIOXIDANT FOR REDUCING AND/OR PREVENTING THE TOXICITY OF A RUBBER COMPOSITION NYCO (FR) 2026-03-19 US disclosed
EP-3755733-B1 NON-LEACHING STYRENE-FREE CURED-IN-PLACE PIPE SYSTEM SUITABLE FOR POTABLE WATER APPLICATIONS AOC LLC (US) 2025-01-15 EP disclosed
US-12186981-B2 Methods and compositions for forming three-dimensional objects by additive fabrication STRATASYS, INC. (US) 2025-01-07 US disclosed
CN-119242013-A Flame retardant material, preparation method thereof and product 江苏博云塑业股份有限公司 2025-01-03 CN disclosed
CN-119081387-A Flame retardant material, preparation method and product thereof 江苏博云塑业股份有限公司 2024-12-06 CN disclosed
CN-115989245-B Polymerization catalyst composition, method for producing polymerization catalyst composition, and method for producing conjugated diene polymer DIC株式会社 2024-08-13 CN disclosed
US-11535692-B2 Non-leaching styrene-free cured-in-place pipe system suitable for potable water applications AOC, LLC 2022-12-27 US disclosed
EP-4077413-A1 COMPOSITION INCLUDING UNSATURATED POLYESTER RESIN, EPOXY RESIN, AND PHOTOINITIATOR AND METHOD OF USING THE SAME 3M Innovative Properties Company (US) 2022-10-26 EP disclosed
US-11479679-B2 2K thermosetting powder coating compositions COVESTRO (NETHERLANDS) B.V. (NL) 2022-10-25 US disclosed
CN-109153870-B Liquid modified PET polyesters for lithographic printing inks 太阳化学公司 2022-08-19 CN disclosed
US-11390023-B2 Methods and compositions for forming three-dimensional objects by additive fabrication COVESTRO (NETHERLANDS) B.V. (NL) 2022-07-19 US disclosed
CN-109476077-B Method and composition for forming three-dimensional objects by additive fabrication 科思创(荷兰)有限公司 2022-04-26 CN disclosed
US-20220081556-A1 COMPOSITION INCLUDING POLYESTER RESIN, ACRYLATE, AND VINYL ESTER AND METHOD OF USING THE SAME 3M INNOVATIVE PROPERTIES COMPANY 2022-03-17 US disclosed
US-20220081555-A1 COMPOSITION INCLUDING POLYESTER RESIN AND VINYL ESTER AND METHOD OF USING THE SAME 3M INNOVATIVE PROPERTIES COMPANY 2022-03-17 US disclosed
WO-2022045282-A1 POLYMERIZATION CATALYST COMPOSITION, METHOD FOR PRODUCING POLYMERIZATION CATALYST COMPOSITION, AND METHOD FOR PRODUCING CONJUGATED DIENE POLYMER DIC株式会社 2022-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078239-A1 USE OF AN ANTIOXIDANT FOR REDUCING AND/OR PREVENTING THE TOXICITY OF A RUBBER COMPOSITION GPX4, RAD50, POT1 HSPA5 706/4885CYP2C9 960/4885CYP2C19 850/4885
US-12509576-B2 Stabilized polymer compositions GPX1, PCBP1, GPX4 HSPA5 198/4885CYP2C9 2327/4885CYP2C19 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.